AKBA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.84%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $562,184.43

Akebia Therapeutics Insider Trading History Chart

Akebia Therapeutics Share Price & Price History

^$1.32

▼ -0.01 (-0.75%)

As of 04/26/2024 03:57 PM ET

Days: 30 | 90 | 365

Move Your Money Before May 22

From Stansberry Research | Ad

The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.

Here's where Dr. David Eifrig says to move your money immediately.

Akebia Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	John P. Butler	CEO	Sell	46,570	$1.58	$73,580.60	2,044,580
2/29/2024	Michel Dahan	COO	Sell	8,661	$1.58	$13,684.38	706,932
2/29/2024	Nicole R Hadas	SVP	Sell	5,974	$1.58	$9,438.92	663,259
2/27/2024	John P. Butler	CEO	Sell	37,733	$1.52	$57,354.16	2,091,150
2/27/2024	Michel Dahan	COO	Sell	10,744	$1.52	$16,330.88	715,593
2/27/2024	Nicole R Hadas	SVP	Sell	7,411	$1.52	$11,264.72	669,233
2/1/2024	John P. Butler	CEO	Sell	46,489	$1.68	$78,101.52	2,128,883
2/1/2024	Steven Keith Burke	SVP	Sell	24,311	$1.68	$40,842.48	711,376
5/25/2023	Michel Dahan	COO	Sell	95,478	$1.22	$116,483.16	574,037
5/25/2023	Nicole R Hadas	SVP	Sell	63,186	$1.22	$77,086.92	524,344
5/16/2023	Steven Keith Burke	SVP	Sell	63,567	$1.07	$68,016.69	530,487
3/1/2023	David A. Spellman	CFO	Sell	7,210	$0.88	$6,344.80	510,050
3/1/2023	John P. Butler	CEO	Sell	91,868	$0.88	$80,843.84	1,568,872
3/1/2023	Michel Dahan	COO	Sell	20,412	$0.88	$17,962.56	269,515
3/1/2023	Nicole R Hadas	SVP	Sell	13,034	$0.88	$11,469.92	287,530
6/3/2022	Steven C Gilman	Director	Sell	4,567	$0.36	$1,644.12	43,430
3/1/2022	David A. Spellman	CFO	Sell	803	$2.17	$1,742.51
2/28/2022	John P. Butler	CEO	Sell	25,053	$2.15	$53,863.95
2/28/2022	Michel Dahan	COO	Sell	6,555	$2.15	$14,093.25
2/28/2022	Steven Keith Burke	SVP	Sell	7,400	$2.15	$15,910.00
2/28/2022	Violetta Cotreau	CAO	Sell	3,946	$2.15	$8,483.90
6/7/2021	Steven C. Gilman	Director	Sell	4,567	$3.32	$15,162.44	47,997

Move Your Money Before May 1

From Stansberry Research | Ad

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

SEC Filings (Institutional Ownership Changes) for Akebia Therapeutics (NASDAQ:AKBA)

33.92% of Akebia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Akebia Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	790,483	$1.45M	0.0%	N/A	0.378%
4/18/2024	Compass Ion Advisors LLC	25,095	$46K	0.0%	N/A	0.012%
4/17/2024	Cannon Global Investment Management LLC	28,000	$51K	0.1%	N/A	0.013%
2/15/2024	Orchard Capital Management LLC	86,826	$0.11M	0.0%	+29.9%	0.044%
2/6/2024	Sapient Capital LLC	200,000	$0.25M	0.0%	N/A	0.101%
2/5/2024	Victory Capital Management Inc.	22,519	$28K	0.0%	-97.0%	0.011%
2/5/2024	Eagle Wealth Strategies LLC	20,017	$25K	0.0%	N/A	0.010%
1/31/2024	Federated Hermes Inc.	866,554	$1.08M	0.0%	-10.2%	0.460%
1/31/2024	Archer Investment Corp	19,800	$25K	0.0%	N/A	0.011%
1/30/2024	Mackenzie Financial Corp	23,159	$29K	0.0%	+37.6%	0.012%
1/29/2024	Sapient Capital LLC	200,000	$0.25M	0.0%	N/A	0.106%
1/16/2024	Raymond James & Associates	29,917	$37K	0.0%	+48.0%	0.016%
12/6/2023	Citigroup Inc.	152,737	$0.17M	0.0%	+311,608.2%	0.081%
11/13/2023	Acadian Asset Management LLC	7,223,488	$8.23M	0.0%	-3.2%	3.834%
11/6/2023	Victory Capital Management Inc.	755,488	$0.86M	0.0%	+14.1%	0.401%
8/7/2023	Acadian Asset Management LLC	7,460,353	$6.82M	0.0%	-0.3%	4.012%
8/3/2023	Mackenzie Financial Corp	27,199	$25K	0.0%	-34.3%	0.015%
7/27/2023	Victory Capital Management Inc.	661,898	$0.61M	0.0%	+156.8%	0.356%
7/27/2023	Virtu Financial LLC	50,633	$46K	0.0%	-48.3%	0.027%
7/27/2023	CWA Asset Management Group LLC	49,000	$45K	0.0%	+69.0%	0.026%
7/19/2023	Eudaimonia Partners LLC	27,144	$25K	0.0%	+123.5%	0.015%
5/15/2023	Alerce Investment Management L.P.	16,205,119	$9.08M	12.0%	+7.4%	8.716%
5/12/2023	Mirabella Financial Services LLP	140,604	$1.83M	0.3%	N/A	0.076%
5/11/2023	Icon Wealth Partners LLC	50,000	$28K	0.0%	N/A	0.027%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	302,977	$0.17M	0.0%	+152.4%	0.163%
5/2/2023	Victory Capital Management Inc.	257,744	$0.14M	0.0%	+1,200.3%	0.140%
5/1/2023	Virtu Financial LLC	97,854	$55K	0.0%	N/A	0.053%
2/15/2023	Alerce Investment Management L.P.	15,090,119	$8.71M	10.0%	+224.3%	8.203%
2/10/2023	Orchard Capital Management LLC	66,826	$39K	0.0%	-73.5%	0.036%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	120,053	$69K	0.0%	-76.5%	0.065%
11/14/2022	Ergoteles LLC	165,237	$52K	0.0%	-80.5%	0.090%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	510,102	$0.16M	0.0%	+124.9%	0.277%
10/26/2022	Allspring Global Investments Holdings LLC	242,866	$76K	0.0%	+43.8%	0.132%
10/26/2022	Wipfli Financial Advisors LLC	200,000	$63K	0.0%	N/A	0.109%
9/16/2022	Federated Hermes Inc.	1,989,467	$0.70M	0.0%	-2.0%	1.082%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	226,770	$80K	0.0%	-51.9%	0.124%
7/29/2022	Russell Investments Group Ltd.	225,640	$78K	0.0%	-11.8%	0.123%
7/25/2022	Allspring Global Investments Holdings LLC	168,942	$59K	0.0%	-51.7%	0.092%
7/19/2022	Icon Wealth Partners LLC	400,132	$0.14M	0.0%	N/A	0.218%
5/16/2022	Orchard Capital Managment LLC	1,762,731	$1.27M	0.4%	+10.6%	0.960%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	471,681	$0.34M	0.0%	+17.2%	0.257%
5/11/2022	GSA Capital Partners LLP	54,370	$39K	0.0%	N/A	0.030%
5/5/2022	Rice Hall James & Associates LLC	513,292	$0.37M	0.0%	+5.6%	0.280%
5/5/2022	Russell Investments Group Ltd.	255,967	$0.18M	0.0%	-19.0%	0.139%
4/25/2022	Assenagon Asset Management S.A.	104,092	$75K	0.0%	N/A	0.059%
2/19/2022	Woodline Partners LP	2,231,966	$5.04M	0.1%	-3.9%	1.276%
2/15/2022	Kennedy Capital Management Inc.	333,841	$0.75M	0.0%	-9.3%	0.191%
2/15/2022	Marshall Wace LLP	4,475,138	$10.11M	0.0%	-35.8%	2.558%
2/14/2022	PDT Partners LLC	433,400	$0.98M	0.1%	-25.5%	0.248%
2/14/2022	Virtus ETF Advisers LLC	69,015	$0.16M	0.1%	+18.5%	0.039%
2/14/2022	Point72 Hong Kong Ltd	13,106	$30K	0.0%	N/A	0.007%
2/14/2022	Rice Hall James & Associates LLC	486,220	$1.10M	0.0%	-14.1%	0.278%
2/14/2022	Blair William & Co. IL	16,599	$38K	0.0%	-27.5%	0.009%
2/10/2022	JPMorgan Chase & Co.	4,432,203	$10.02M	0.0%	-2.9%	2.533%
2/10/2022	Rafferty Asset Management LLC	738,075	$1.67M	0.0%	+9.5%	0.422%
2/10/2022	Teacher Retirement System of Texas	32,286	$73K	0.0%	+37.2%	0.018%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	402,416	$0.91M	0.0%	-6.6%	0.230%
2/9/2022	Principal Financial Group Inc.	258,563	$0.58M	0.0%	-52.1%	0.148%
2/9/2022	BNP Paribas Arbitrage SA	70,923	$0.16M	0.0%	-9.1%	0.041%
2/9/2022	Dimensional Fund Advisors LP	2,593,841	$5.86M	0.0%	+23.8%	1.483%
2/8/2022	Swiss National Bank	364,785	$0.82M	0.0%	+8.5%	0.208%
2/8/2022	Northern Trust Corp	1,746,054	$3.95M	0.0%	-1.5%	0.998%
2/7/2022	SG Americas Securities LLC	43,176	$98K	0.0%	-61.2%	0.025%
2/3/2022	Virginia Retirement Systems ET AL	111,800	$0.25M	0.0%	-29.6%	0.064%
2/3/2022	Nisa Investment Advisors LLC	356,208	$0.71M	0.0%	-1.7%	0.204%
2/2/2022	New York State Common Retirement Fund	123,867	$0.28M	0.0%	+42.9%	0.071%
1/28/2022	Allspring Global Investments Holdings LLC	307,912	$0.70M	0.0%	N/A	0.176%
1/21/2022	Russell Investments Group Ltd.	316,047	$0.71M	0.0%	-22.3%	0.181%
1/20/2022	Ardent Capital Management Inc.	168,811	$0.38M	0.3%	N/A	0.096%
12/14/2021	UBS Asset Management Americas Inc.	174,173	$0.50M	0.0%	-12.4%	0.100%
11/16/2021	Opaleye Management Inc.	311,300	$0.90M	0.2%	N/A	0.178%
11/16/2021	Two Sigma Securities LLC	21,361	$62K	0.0%	N/A	0.012%
11/16/2021	Maverick Capital Ltd.	105,816	$0.31M	0.0%	N/A	0.060%
11/16/2021	Metropolitan Life Insurance Co NY	48,214	$0.14M	0.0%	+72.5%	0.028%
11/15/2021	California State Teachers Retirement System	216,225	$0.62M	0.0%	-1.8%	0.124%
11/15/2021	Marshall Wace LLP	6,968,811	$20.07M	0.1%	+69.6%	3.983%
11/15/2021	Voya Investment Management LLC	115,329	$0.33M	0.0%	+8.2%	0.066%
11/15/2021	Dimensional Fund Advisors LP	2,095,763	$6.04M	0.0%	-38.5%	1.198%
11/15/2021	Franklin Resources Inc.	122,000	$0.35M	0.0%	N/A	0.070%
11/15/2021	GSA Capital Partners LLP	254,376	$0.73M	0.1%	N/A	0.145%
11/12/2021	Renaissance Technologies LLC	949,927	$2.74M	0.0%	-48.0%	0.543%
11/12/2021	Jump Financial LLC	152,300	$0.44M	0.0%	-34.6%	0.087%
11/12/2021	The Manufacturers Life Insurance Company	102,890	$0.30M	0.0%	+8.4%	0.059%
11/12/2021	Credit Suisse AG	231,365	$0.67M	0.0%	+130.0%	0.132%
11/12/2021	Geode Capital Management LLC	3,229,943	$9.30M	0.0%	+10.5%	1.846%
11/12/2021	E Fund Management Co. Ltd.	37,123	$0.11M	0.0%	N/A	0.021%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	430,671	$1.24M	0.0%	+103.8%	0.246%
11/10/2021	Goldman Sachs Group Inc.	514,258	$1.48M	0.0%	-83.5%	0.295%
11/10/2021	Panagora Asset Management Inc.	249,815	$0.72M	0.0%	+253.9%	0.143%
11/10/2021	Citigroup Inc.	448,643	$1.29M	0.0%	-50.8%	0.256%
11/10/2021	Rafferty Asset Management LLC	673,939	$1.94M	0.0%	+13.3%	0.385%
11/9/2021	Teacher Retirement System of Texas	23,527	$68K	0.0%	+38.7%	0.013%
11/9/2021	Rice Hall James & Associates LLC	566,026	$1.63M	0.1%	+2.4%	0.324%
11/9/2021	Barclays PLC	188,357	$0.54M	0.0%	+11.3%	0.108%
11/9/2021	BlackRock Inc.	14,052,487	$40.47M	0.0%	+6.7%	8.051%
11/9/2021	Principal Financial Group Inc.	539,832	$1.55M	0.0%	-1.5%	0.309%
11/8/2021	State Board of Administration of Florida Retirement System	67,088	$0.19M	0.0%	+20.5%	0.038%
11/8/2021	Swiss National Bank	336,085	$0.97M	0.0%	+4.5%	0.193%
11/8/2021	Russell Investments Group Ltd.	406,680	$1.17M	0.0%	-11.4%	0.233%
11/4/2021	Deutsche Bank AG	115,185	$0.33M	0.0%	+5.0%	0.066%

Data available starting January 2016

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $1.32

$1.29

$1.35

50 Day Range

MA: $1.58

$1.33

$2.24

52 Week Range

Now: $1.32

$0.78

$2.48

Volume

2,129,932 shs

Average Volume

4,237,651 shs

Market Capitalization

$276.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.79

Who are the company insiders with the largest holdings of Akebia Therapeutics?: Akebia Therapeutics' top insider shareholders include:
John P Butler (CEO)
Michel Dahan (COO)
Steven Keith Burke (SVP)
Nicole R Hadas (SVP)
David A Spellman (CFO)
Steven C Gilman (Director)
Learn More about top insider investors at Akebia Therapeutics.
Who are the major institutional investors of Akebia Therapeutics?: Akebia Therapeutics' top institutional investors include:
Assenagon Asset Management S.A. — 0.38%
Cannon Global Investment Management LLC — 0.01%
Compass Ion Advisors LLC — 0.01%
Learn More about top institutional investors of Akebia Therapeutics stock.
Which institutional investors are buying Akebia Therapeutics stock?: Within the last quarter, AKBA stock was purchased by institutional investors including:
Assenagon Asset Management S.A.
Cannon Global Investment Management LLC
Compass Ion Advisors LLC